HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsufumi Nakahashi Selected Research

ensitrelvir

12/2022Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsufumi Nakahashi Research Topics

Disease

1COVID-19
12/2022

Drug/Important Bio-Agent (IBA)

1ensitrelvirIBA
12/2022
1Protease Inhibitors (Protease Inhibitor)IBA
12/2022